Surgical Robots Market

Market Definition

Surgical robots are advanced robotic systems designed to assist surgeons during medical procedures by providing enhanced precision, control, and flexibility. These robots often include robotic arms, cameras, and specialized tools, allowing for minimally invasive surgeries with smaller incisions, reduced recovery time, and improved outcomes.

Surgical Robots Market Overview

The global surgical robots market size was valued at USD 8.56 billion in 2023 and is projected to grow from USD 10.17 billion in 2024 to USD 39.88 billion by 2031, exhibiting a CAGR of 21.56% during the forecast period.

The surgical robot market has been registering significant growth, due to advancements in robotic technology, increasing demand for minimally invasive surgeries, and rising healthcare needs globally. Key factors driving the market include the growing preference for precision and minimally invasive procedures, enhanced surgical outcomes, and the ability to reduce recovery time for patients.

Major companies operating in the surgical robots industry are Intuitive Surgical, Stryker, Medtronic, Zimmer Biomet, Smith+Nephew, CMR Surgical, Accuray Incorporated, Globus Medical, Virtuoso Surgical, Inc., Johnson & Johnson Services, Inc., Siemens AG, PROCEPT BioRobotics Corporation, KARL STORZ, Diligent Robotics Inc., and Renishaw plc.

Additionally, the rising adoption of robotic systems in both developed and emerging markets, along with the integration of Artificial Intelligence (AI) and Machine Learning (ML), is expected to further propel the market. Despite the high initial investment costs, the long-term benefits of surgical robots, including cost savings and improved patient outcomes, are fueling the market.

• In 2024, the Toulouse University Hospital acquired the Epione robotic system to enhance minimally invasive tumor treatments. Developed by Quantum Surgical, Epione uses advanced 2D/3D imaging and fusion software to assist physicians in precisely positioning ablation needles for the curative treatment of abdominal and lung tumors. The system improves accuracy, reduces procedure time, and enhances patient outcomes.

Key Highlights:

• The surgical robots industry size was valued at USD 8.56 billion in 2023.
• The market is projected to grow at a CAGR of 21.56% from 2024 to 2031.
• North America held a market share of 40.12% in 2023, with a valuation of USD 3.43 billion.
• The instruments & accessories segment garnered USD 4.29 billion in revenue in 2023.
• The general surgery segment is expected to reach USD 12.59 billion by 2031.
• The AI-powered surgical robots segment is expected to reach USD 24.18 billion by 2031.
• The hospitals segment is expected to reach USD 22.81 billion by 2031.
• The market in Asia Pacific is anticipated to grow at a CAGR of 23.82% during the forecast period.

Market Driver

"Rising Demand for Minimally Invasive Surgeries and Development of 3D Preoperative Planning Systems"

The surgical robots market is registering significant growth, due to the increasing demand for minimally invasive surgeries on account of their benefits like quicker recovery times, reduced risks, and shorter hospital stays. This factor is pushing the adoption of robotic systems that enable more precise and controlled procedures.

Another important factor is the rapid advancement of technology, particularly in the fields of AI and robotics. These innovations have greatly enhanced the precision, visualization, and overall effectiveness of surgical robots, making them valuable tools across a wide range of specialties.

Furthermore, the development of 3D preoperative planning systems, which allow for accurate and radiation-free surgical planning, is transforming the way surgeries are performed.

By providing surgeons with detailed, personalized visualizations of a patient's anatomy before the procedure, these technologies enable more informed decision-making and improved surgical precision, ultimately leading to better patient outcomes.

• For instance, in August 2024, Smith+Nephew and JointVue formed a co-marketing agreement for JointVue’s OrthoSonic 3D Surgery Planning Technology, an ultrasound device that creates 3D preoperative plans without radiation. This technology, used alongside Smith+Nephew’s CORI Surgical System, enables personalized knee arthroplasty plans, improving patient satisfaction and operating room efficiency.

Market Challenge

"High Cost of System and Lack of Skilled Professionals"

The surgical robots market encounters multiple challenges that hinder their widespread adoption. One of the primary challenges is the high cost associated with acquiring and maintaining surgical robots. The initial investment for purchasing robotic systems can be prohibitively expensive, especially for smaller hospitals and surgical centers with limited budgets.

Ongoing costs related to maintenance, staff training, and support adds to the financial burden. A solution to this issue lies in the development of more affordable robotic systems and the introduction of flexible financing models, making it easier for healthcare facilities to integrate these technologies without straining their budgets.

Another challenge is the shortage of skilled professionals capable of operating advanced robotic systems. Robotic surgeries require specialized knowledge, thus, hospitals often struggle to ensure that their surgeons and staff are fully trained.

Manufacturers and healthcare organizations are focusing on comprehensive training programs and simulation tools that offer hands-on experience, ensuring that medical professionals are well-equipped to use these technologies effectively.

• For instance, in August 2024, Apollo Cancer Centre Bengaluru launched South Asia’s first CyberKnife S7 FIM Robotic Radiosurgery System, offering advanced non-invasive treatment for various cancers. The center also introduced the CyberKnife Academia in partnership with Accuray, providing specialized training for oncology professionals across South Asia.

Market Trend

"Adoption of Robotic-assisted Surgeries and Integration of AI"

The surgical robots market is evolving with technological advancements and industry innovations. The growing adoption of robotic-assisted surgeries across a wide range of specialties is reshaping the healthcare landscape.

Procedures such as minimally invasive surgeries, orthopedic procedures, and spinal surgeries are becoming increasingly common as more hospitals and surgical centers integrate robotic systems, broadening the application of surgical robots.

The rise of hybrid systems that combine robotic assistance with augmented reality (AR) and AI is another key development, enhancing surgical precision and decision-making. These hybrid technologies offer surgeons real-time data, 3D visualizations, and predictive analytics, enabling more accurate and personalized treatments. Additionally, the shift toward making surgical robots more affordable and accessible is gaining momentum.

• In October 2024, ZEISS introduced the KINEVO 900 S Robotic Visualization Systems. This advanced system features 4K 3D digital visualization, DepthPro Mode for greater depth of field, and AI-driven AutoCenter for optimized tissue illumination. It supports exoscopic and ocular views, enhancing surgeon ergonomics and precision. The system also offers connectivity solutions like ZEISS Surgical Cloud for streamlined data management and real-time collaboration.

Surgical Robots Market Report Snapshot

Market Segmentation:

• By Product Type (Surgical Robotic Systems, Instruments & Accessories, Services): The instruments & accessories segment earned USD 4.29 billion in 2023, due to the growing demand for specialized tools and frequent replacements in robotic surgeries.
• By Application (General Surgery, Orthopedic Surgery, Neurosurgery, Gynecological Surgery, Urological Surgery, Cardiovascular Surgery, and Other Specialties): The general surgery segment held 30.12% share of the market in 2023, due to the widespread use of robotic systems for minimally invasive procedures and their ability to improve precision in common surgical operations.
• By Technology (AI-powered Surgical Robots, Cloud-based Surgical Systems, and Telerobotics & Remote Surgery): The AI-powered surgical robots segment is projected to reach USD 24.18 billion by 2031, owing to advancements in AI that enhance surgical precision, decision-making, and personalized patient care.
• By End User (Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics): The hospitals segment is projected to reach USD 22.81 billion by 2031, owing to the high demand for advanced surgical procedures and the capability of hospitals to invest in and maintain sophisticated robotic systems.

Surgical Robots Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

North America accounted for a substantial surgical robots market share of 40.12% in 2023, with a valuation of USD 3.43 billion. This dominance is attributed to the advanced healthcare infrastructure, high adoption of cutting-edge technologies, and the presence of leading surgical robot manufacturers in the region.

Additionally, a strong focus on Research and Development (R&D), along with government support for medical innovation, has contributed to the widespread use of surgical robots.

The demand for minimally invasive surgeries, driven by improved patient outcomes and reduced recovery times, further fuels the market in this region. Hospitals and healthcare facilities in this region are increasingly investing in robotic systems to enhance surgical precision and improve operational efficiency.

• In November 2024, Johnson & Johnson MedTech announced FDA approval of the investigational device exemption (IDE) for its OTTAVA robotic surgical system, allowing clinical trials to begin at U.S. sites. OTTAVA is designed to address unmet needs in robotic surgery by integrating four low-profile robotic arms into the operating table, enabling more space in the OR and supporting multiple surgical modalities.

Asia Pacific is expected to register the fastest growth in the surgical robots industry, with a projected CAGR of 23.82% over the forecast period. This rapid growth is driven by a combination of factors, including the expanding healthcare infrastructure, increasing investments in medical technology, and the growing prevalence of chronic diseases such as cancer, cardiovascular issues, and neurological disorders.

Countries like China, Japan, and India are registering significant growth in robotic-assisted surgeries, aided by government initiatives to improve healthcare services and upgrade surgical capabilities. Furthermore, the rising awareness of the advantages of minimally invasive procedures, such as faster recovery and reduced complication rates, is driving the adoption of surgical robots.

The market in Asia Pacific is poised to register significant expansion over the coming years, as healthcare spending continues to rise in the region, along with improvements in access to healthcare.

Regulatory Frameworks

• The Food and Drug Administration (FDA) regulates surgical robots in the U.S. The FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating medical devices, including surgical robots.
• In Europe, surgical robots are regulated under the European Medical Device Regulation (MDR), which classifies them as medical devices. They must comply with the standards set by the MDR to be marketed and used within the EU. No specific regulatory body is dedicated solely to surgical robots; however, these devices are governed by the broader medical device regulations that ensure their safety, efficacy, and quality.
• In China, the National Medical Products Administration (NMPA) governs the regulatory approval and oversight of surgical robots. It ensures that robotic systems meet the necessary safety and efficacy standards before being introduced to the market.
• In Japan, the Ministry of Health, Labour and Welfare (MHLW) regulates surgical robots. The agency ensures that robotic systems meet stringent safety and performance criteria for medical use in Japan.
• In India, the Central Drugs Standard Control Organization (CDSCO) is responsible for regulating medical devices, including surgical robots. It ensures that robotic systems adhere to required quality standards and are safe for use in Indian healthcare facilities.

Competitive Landscape:

The surgical robots industry is characterized by several participants, including established corporations and rising organizations. Key strategies within the market include partnerships, collaborations, and mergers and acquisitions, allowing companies to expand their portfolios, access new markets, and leverage complementary technologies.

• For instance, in August 2024, Johnson & Johnson MedTech launched the VELYS SPINE robotic system by DePuy Synthes. Developed with eCential Robotics, the FDA-cleared system integrates with DePuy Synthes’ spine portfolio and features adaptive tracking and trajectory assistance for enhanced surgical precision and control to surgeons.

Additionally, players are focusing on improving user experience, integrating AI and ML, and enhancing robotic systems with features like remote surgery capabilities and cloud-based systems. The growing demand for minimally invasive surgeries and the rising adoption of robotic systems in hospitals, ambulatory surgical centers, and specialty clinics are driving the market.

Companies are also working to meet regulatory standards and address challenges related to high initial investment costs and ongoing maintenance, ensuring long-term sustainability and success.

List of Key Companies in Surgical Robots Market:

• Intuitive Surgical
• Stryker
• Medtronic
• Zimmer Biomet
• Smith+Nephew
• CMR Surgical
• Accuray Incorporated
• Globus Medical
• Virtuoso Surgical, Inc.
• Johnson & Johnson Services, Inc.
• Siemens AG
• PROCEPT BioRobotics Corporation
• KARL STORZ
• Diligent Robotics Inc.
• Renishaw plc.

 Recent Developments (M&A/Partnerships/Agreements/New Product Launch)

• In October 2024, Jupiter Medical Center acquired its third orthopedic robot, the CORI Robotic-Assisted Surgical System from Smith+Nephew. This advanced technology enhances joint replacement surgeries by providing precise planning without the need for CT/MRI scans. The CORI system generates a 3D digital model of the patient's knee, allowing surgeons to customize the procedure and improve implant placement accuracy.
• In June 2024, Asensus Surgical, Inc. entered into a definitive merger agreement with KARL STORZ Endoscopy-America, Inc., under which KARL STORZ will acquire all outstanding shares of Asensus. The merger will enhance KARL STORZ’s presence in the robotic surgery market, particularly with the development of the next-generation LUNA system.
• In June 2024, Intuitive received FDA clearance for revised labeling of da Vinci X and Xi systems for radical prostatectomy, confirming that robotic-assisted prostatectomy offers comparable five- to 10-year survival rates to traditional surgery. This approval was based on real-world evidence and highlights the benefits of robotic surgery, such as shorter hospital stays and reduced blood loss.
• In May 2024, Sony announced the development of a microsurgery assistance robot capable of automatic surgical instrument exchange and precision control. Unveiled at ICRA2024, the prototype is designed to assist in delicate procedures on small tissues like veins and nerves by replicating surgeons' hand movements with high precision. An experiment at Aichi Medical University successfully demonstrated the system’s ability to perform microvascular anastomosis.
• In February 2024, THINK Surgical and Maxx Orthopedics announced a collaboration to add Maxx's Freedom Knee System to THINK's ID-HUB database for use with the TMINI Robotic System. This integration expands implant options for robotic-assisted knee replacements.